Lung Cancer Trials Ask AI to find trials
CompletedPhase 4NCT03369847
Official study title

Inhaled Steroids for Pediatric Asthma at Pediatric Emergency Medicine Discharge

Study summary

This study evaluates the initiation of inhaled corticosteroids upon discharge from the pediatric emergency room in children under 18 presenting with asthma exacerbation. Half of the patients will receive a prescription for inhaled corticosteroids in addition to standard care, and half of the patients will receive standard card alone.

Ask AI to explain this study
Start here

Key things to know

Main goalTreatment

This describes the study’s primary purpose.

What is being studiedbudesonide, beclomethasone

The study team can explain what participation involves.

Who it may be forAsthma · Pediatric ALL

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Jul 18, 2019 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Phase 4

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?New York City Health and Hospitals Corporation

Study sponsor

01
Study overview

What this study is about

Purpose
Treatment
Study type
Interventional
Phase
Phase 4
Sponsor
New York City Health and Hospitals Corporation
Interventions being studied
Drug: budesonide, beclomethasone
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • Chief complaint consistent with asthma exacerbation
  • Previous diagnosis of asthma by a physician OR one major in the Asthma Predictive Index (API) with two prior episodes of wheezing in the past year.
  • Major criteria in the API: parent with asthma, patient with eczema, evidence of sensitization to allergens in the air
  • Received oral corticosteroids as part of treatment during this visit for acute asthma exacerbation.
  • Deemed well enough after interventions to be discharged by the treating physician.
  • If \<5 years of age, possession of nebulizer machine at home.
Reasons someone may not be able to joinExclusion criteria
  • Received asthma controller medications within four weeks prior to presentation
  • Allergy to intervention asthma controller medications.

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Kings County Hospital CenterBrooklyn, New York

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jul 18, 2019. Always confirm current availability with the study team.

View original record ↗